Untitled 2 0002 Kier Logo

“T&T Facades delivered for us a façade package which included SFS framing, secret fix Alucobond rain screen cladding, louvres and windows.

Throughout the project, T&T proactively assisted with value engineering to help us meet the required budget while maintaining the original design intent that the project demanded. Both ourselves (Kier) and the client are extremely happy with the quality of the finish and safety on site was always paramount on T&T’s agenda. Our greatest concern, with it being a hidden fix cladding system was how T&T would ensure consistency of panel joints, but we needn’t have worried due to the high quality of the install all parties are more than please with the final product!  Our relationship throughout was very collaborative and supportive. There were some outstanding members of the installation team who went above and beyond to get the job delivered to the required standard.

I have no hesitation in recommending T&T and we are already in talks on future projects”.

Joe Riches Senior Site Manager, Kier. SCCI>

As a result of an incredible fundraising project, Southampton University, in conjunction with Southampton General Hospital commissioned the build of a unique cancer research facility. The new 4000m², four storey centre was built on the old General Hospital site.

T&T provided client Kier with a bespoke, innovative, value engineered façade solution produced in an Alucobond rainscreen cladding product specifically sourced in the unusual colour of Midnight Copper. This not only retained the architects vision but also provided a cost effective solution for our client.

There were a number of aesthetic design features on the project which included an extensive projection feature in the form of ‘fins’ made from the same Alucobond panels used on the facade which were designed to cover the plant room louvres. T&T had to precision engineer a custom router to create the desired shape.

The new centre, the first of its kind in the UK, will be home to world class research facilities and will build on the University’s global reputation for ground-breaking research in this area, enabling it to accelerate the development of immunotherapy treatments and deliver cures for cancer more effectively and quickly.